{"id":"https://openalex.org/W2947440683","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.6020","title":"Alliance A091404: A phase II study of enzalutamide (NSC# 766085) for patients with androgen receptor-positive salivary cancers.","display_name":"Alliance A091404: A phase II study of enzalutamide (NSC# 766085) for patients with androgen receptor-positive salivary cancers.","publication_year":2019,"publication_date":"2019-05-20","ids":{"openalex":"https://openalex.org/W2947440683","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.6020","mag":"2947440683"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2019.37.15_suppl.6020","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.6020","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.6020","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036572642","display_name":"Alan Loh Ho","orcid":"https://orcid.org/0000-0002-6885-3742","observed_orcids":["https://orcid.org/0000-0002-6885-3742"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Loh Ho","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008026182","display_name":"Nathan R. Foster","orcid":"https://orcid.org/0000-0002-2874-1295","observed_orcids":["https://orcid.org/0000-0002-2874-1295"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathan R. Foster","raw_affiliation_strings":["Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008995447","display_name":"Alexander J. Zoroufy","orcid":"https://orcid.org/0000-0003-2928-4484","observed_orcids":["https://orcid.org/0000-0003-2928-4484"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander J. Zoroufy","raw_affiliation_strings":["Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022036818","display_name":"Francis Paul Worden","orcid":"https://orcid.org/0000-0002-6632-4951","observed_orcids":["https://orcid.org/0000-0002-6632-4951"]},"institutions":[{"id":"https://openalex.org/I4390039285","display_name":"U-M Rogel Cancer Center","ror":"https://ror.org/05asdy483","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445","https://openalex.org/I4390039285"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francis P. Worden","raw_affiliation_strings":["University of Michigan Rogel Cancer Center, Ann Arbor, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan Rogel Cancer Center, Ann Arbor, MI;","institution_ids":["https://openalex.org/I4390039285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037908919","display_name":"Katharine Andress Rowe Price","orcid":"https://orcid.org/0000-0002-5738-1866","observed_orcids":["https://orcid.org/0000-0002-5738-1866"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katharine Andress Rowe Price","raw_affiliation_strings":["Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064319129","display_name":"Douglas R. Adkins","orcid":"https://orcid.org/0000-0003-3207-8227","observed_orcids":["https://orcid.org/0000-0003-3207-8227"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas Adkins","raw_affiliation_strings":["Washington University School of Medicine, St. Louis, MO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine, St. Louis, MO;","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088419169","display_name":"Daniel W. Bowles","orcid":"https://orcid.org/0000-0003-1406-0963","observed_orcids":["https://orcid.org/0000-0003-1406-0963"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel W. Bowles","raw_affiliation_strings":["University of Colorado, Aurora, CO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado, Aurora, CO;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071669347","display_name":"Hyunseok Kang","orcid":"https://orcid.org/0000-0001-5758-8202","observed_orcids":["https://orcid.org/0000-0001-5758-8202"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hyunseok Kang","raw_affiliation_strings":["The Sidney Kimmel Comprehensive Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Sidney Kimmel Comprehensive Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, MD;","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023000705","display_name":"Barbara Ann Burtness","orcid":"https://orcid.org/0000-0003-4660-1859","observed_orcids":["https://orcid.org/0000-0003-4660-1859"]},"institutions":[{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara Burtness","raw_affiliation_strings":["Yale University School of Medicine and Yale Cancer Center, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale University School of Medicine and Yale Cancer Center, New Haven, CT;","institution_ids":["https://openalex.org/I2802730090","https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061365371","display_name":"Eric Jeffrey Sherman","orcid":"https://orcid.org/0000-0002-4960-4783","observed_orcids":["https://orcid.org/0000-0002-4960-4783"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Jeffrey Sherman","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108265719","display_name":"Roscoe F. Morton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roscoe F. Morton","raw_affiliation_strings":["Medical Oncology and Hematology Associates of Iowa, Des Moines, IA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology and Hematology Associates of Iowa, Des Moines, IA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024957945","display_name":"Nora Katabi","orcid":"https://orcid.org/0000-0003-2974-3046","observed_orcids":["https://orcid.org/0000-0003-2974-3046"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nora Katabi","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083373965","display_name":"Pamela N. M\u00fcnster","orcid":"https://orcid.org/0000-0002-2074-0984","observed_orcids":["https://orcid.org/0000-0002-2074-0984","https://orcid.org/0009-0009-4141-2312"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pamela N. Munster","raw_affiliation_strings":["University of California San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006913373","display_name":"Gary K. Schwartz","orcid":"https://orcid.org/0000-0003-1813-5061","observed_orcids":["https://orcid.org/0000-0003-1813-5061"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary K. Schwartz","raw_affiliation_strings":["Columbia University Medical Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University Medical Center, New York, NY;","institution_ids":["https://openalex.org/I2799503643"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"15_suppl","first_page":"6020","last_page":"6020"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11035","display_name":"Salivary Gland Tumors Diagnosis and Treatment","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11035","display_name":"Salivary Gland Tumors Diagnosis and Treatment","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11521","display_name":"Salivary Gland Disorders and Functions","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/enzalutamide","display_name":"enzalutamide","score":0.9950000047683716},{"id":"https://openalex.org/keywords/antiandrogen-therapy","display_name":"antiandrogen therapy","score":0.8569999933242798},{"id":"https://openalex.org/keywords/androgen-receptor-targeted-therapy","display_name":"androgen receptor-targeted therapy","score":0.7269999980926514},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6669999957084656},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9509999752044678},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.4950000047683716},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.414000004529953},{"id":"https://openalex.org/keywords/simon-s-two-stage-design","display_name":"Simon two-stage design","score":0.6790000200271606}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9020854234695435},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.7576247453689575},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.7521129846572876},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.6601008772850037},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6334432363510132},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4869576394557953},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.48161429166793823},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4641597867012024},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.46214044094085693},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4499002695083618},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4205184876918793},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2856920063495636},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.2800101637840271}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2019.37.15_suppl.6020","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.6020","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.6020","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4286717006","https://openalex.org/W7162538200","https://openalex.org/W4311985055","https://openalex.org/W4400118049","https://openalex.org/W4410804136","https://openalex.org/W4379281798","https://openalex.org/W7154565406","https://openalex.org/W7172323036","https://openalex.org/W4286298713","https://openalex.org/W3204550250"],"abstract_inverted_index":{"6020":[0],"Background:":[1],"A":[2,88],"subset":[3],"of":[4,228,269,321,330,332,342],"salivary":[5],"gland":[6],"cancer":[7],"(SGCs)":[8],"express":[9],"the":[10,19,73,111,144,168,183,198,232,303,318,328,340],"androgen":[11],"receptor":[12],"(AR).":[13],"This":[14,301],"phase":[15],"II":[16],"trial":[17,306,360],"evaluated":[18],"anti-androgen":[20],"enzalumatide":[21],"(Astellas)":[22],"for":[23,155,311],"patients":[24,129],"with":[25,44,223,252,350],"AR+":[26,33,312,343],"SGCs.":[27,313],"Methods:":[28],"Locally":[29],"advanced/unresectable":[30],"or":[31],"metastatic":[32],"SGCs":[34],"were":[35,79,131,180,257],"enrolled":[36,132],"(AR":[37],"status":[38],"was":[39,47,55,64,92,161,277,286,294,323],"centrally":[40],"confirmed).":[41],"Prior":[42],"therapy":[43],"AR-targeted":[45,253],"drugs":[46],"allowed.":[48],"Enzalutamide":[49],"160":[50],"mg":[51],"orally":[52],"once":[53],"daily":[54],"given":[56],"(1":[57],"cycle=":[58],"28":[59],"days).":[60],"The":[61,219,314,335],"primary":[62,199],"endpoint":[63,200],"confirmed":[65,152,181,259],"response":[66],"(RR)":[67],"according":[68],"to":[69,94,117,164,202,316,327],"RECIST":[70],"v1.1":[71],"within":[72,182],"first":[74,112,145,184,233,304],"8":[75,185,206],"cycles.":[76],"Secondary":[77],"endpoints":[78],"progression-free":[80],"survival":[81,84],"(PFS),":[82],"overall":[83],"(OS),":[85],"and":[86,210,291],"safety.":[87],"Simon-Optimal":[89],"two-stage":[90],"design":[91],"used":[93],"detect":[95],"a":[96,212,266],"20%":[97],"RR":[98],"(vs.":[99],"5%)":[100],"(alpha":[101],"=":[102,105],"5%;":[103],"beta":[104],"90%).":[106],">":[107,119],"1":[108,258],"response(s)":[109],"in":[110,140,325],"21":[113,146],"would":[114,122],"trigger":[115],"accrual":[116],"41;":[118],"4":[120],"responses":[121,256],"be":[123],"considered":[124],"promising.":[125],"Results:":[126],"46":[127,169],"eligible":[128],"(pts)":[130],"(40":[133],"M,":[134],"6":[135],"F;":[136],"median":[137,267,292],"age":[138],"65)":[139],"22":[141],"months.":[142],"In":[143],"pts,":[147,170],"we":[148],"initially":[149],"had":[150,172,238],"2":[151,179],"PRs":[153,193],"allowing":[154],"full":[156],"study":[157],"accrual,":[158],"though":[159,177],"one":[160],"later":[162],"changed":[163],"stable":[165,239],"disease.":[166],"Among":[167,247],"7":[171,261],"PR":[173,225,234],"as":[174,244],"best":[175,245,255],"response,":[176],"only":[178],"cycles":[186,207],"(4%":[187],"(95%":[188,279,288,297],"CI:":[189,280,289,298],"0.5-15%).":[190],"Two":[191],"other":[192,220,351],"did":[194],"not":[195],"count":[196],"towards":[197],"due":[201,324],"1)":[203],"development":[204],"beyond":[205],"(cycles":[208],"12-18)":[209],"2)":[211],"confirmatory":[213],"scan":[214],"completed":[215],"<4":[216],"weeks":[217],"apart.":[218],"3":[221,263],"pts":[222,237,242,249],"unconfirmed":[224],"developed":[226],"progression":[227],"disease":[229],"(PD)":[230],"after":[231],"scan.":[235],"24":[236],"disease;":[240],"15":[241],"PD":[243],"response.":[246],"11":[248],"previously":[250,348],"treated":[251,349],"therapy,":[254],"PR,":[260],"SD,":[262],"PD.":[264],"With":[265],"follow-up":[268],"11.7":[270],"months":[271],"(mo),":[272],"OS":[273],"at":[274,283],"12":[275,284],"mo":[276,285,296],"66%":[278],"52-83%),":[281],"PFS":[282,293],"24%":[287],"14-42%),":[290],"5.5":[295],"3.7-7.3).":[299],"Conclusions:":[300],"is":[302],"prospective":[305],"evaluating":[307],"an":[308],"antiandrogen":[309],"alone":[310],"failure":[315],"meet":[317],"protocol-defined":[319],"measure":[320],"success":[322],"part":[326],"lack":[329],"durability":[331],"initial":[333],"responses.":[334],"clinical":[336],"activity":[337],"observed":[338],"suggests":[339],"AR-dependence":[341],"SGCs,":[344],"even":[345],"among":[346],"those":[347],"hormonal":[352],"therapies.":[353],"Support:":[354],"U10CA180821,":[355],"U10CA180882;":[356],"Astellas;":[357],"https://acknowledgments.alliancefound.org.":[358],"Clinical":[359],"information:":[361],"NCT02749903.":[362]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-06-07T00:00:00"}